"I do want to apologize for misleading people," Sharhonda Blue said on TikTok after experiencing extreme pain with her own IUD insertion Courtesy Sharhonda Blue A TikToker from San Antonio is making ...

Question: I’m considering getting the coil instead of going back on the pill. I like the idea of something long-term, but I’ve heard horror stories about very painful insertion, heavy bleeding, mood ...

Chelsea Handler has shared candid stories about her dating life, sex and other romantic outlooks across the years ...

One positive trend in women’s health in the past several years is the fact that for the first time, the pain women experience during IUD insertion has bubbled to the forefront of conversations and is ...

An NPR listener says they've become increasingly concerned by their friends' marriage and feels a sense of duty to fix their relationship problems. Can they tell them what they really think?

To help boost the pipeline for career development, RMU developed the Rocky Mountain University Nurse Practitioner hybrid programs for working nurses who want to advance their careers without stepping ...

For the first few years after Victoria Stephens had the ­contraceptive implant Nexplanon placed just under the skin in her left arm, it was 'perfect', she says.

Eighty-five original research projects from aspiring physician-scientists were on display at the 2026 Medical Student Research Forum at the Jacobs School of Medicine and Biomedical Sciences.

Chelsea Handler urges men to get a vasectomy while criticizing IUDs as a mouse trap for the uterus in a topless Instagram video talking about birth control ...

Organon (NYSE: OGN), a global healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day, announced today that it has entered into an agreement to ...

The newly-approved device requires only that patients swallow it in their doctor's office to achieve weight loss, according ...

Under an agreement announced Monday, Feb. 23, Organon will pay $27.5 million upfront for the right to market Sebela’s Miudella, billed as the first FDA-approved device of its kind in 40 years.